Safety of Novel Amino-5-laevulinate Photosensitizer Precursors in Photodynamic Therapy for Healthy Human Skin.
Department of Dermatology and Allergology, Helsinki University Central Hospital, FIN-00029 Helsinki, Finland. noora.neittaanmaki@fimnet.fi.
Noora
N
Neittaanmäki-Perttu
Eerika
E
Neittaanmäki
Ilkka
I
Pölönen
Erna
E
Snellman
Mari
M
Grönroos
D000279:Administration, Cutaneous; D000328:Adult; D000622:Aminolevulinic Acid / Q000008:administration & dosage* / Q000009:adverse effects / Q000031:analogs & derivatives; D004311:Double-Blind Method; D004890:Erythema / Q000209:etiology; D064368:Healthy Volunteers; D006801:Humans; D010146:Pain / Q000209:etiology; D010778:Photochemotherapy / Q000379:methods*; D017319:Photosensitizing Agents / Q000008:administration & dosage* / Q000009:adverse effects; D010865:Pilot Projects; D011355:Prodrugs / Q000008:administration & dosage* / Q000009:adverse effects; D012867:Skin / Q000187:drug effects* / Q000528:radiation effects*; D013997:Time Factors
C570703:BF-200 ALA; D017319:Photosensitizing Agents; D011355:Prodrugs; C475457:methyl 5-aminolevulinate; D000622:Aminolevulinic Acid; C419924:5-aminolevulinic acid hexyl ester